Q-POC™ SARS-CoV-2
From collecting samples to reading results, the Q-POC™ SARS-CoV-2 assay has been developed considering patient and user experience at every step of the COVID-19 testing process. The test delivers rapid PCR results in approximately 30 minutes at the Point of Need, on the accurate and portable Q-POC™ platform.
Q-POC (TM) SARS-CoV-2 assay.
Q-POC (TM) SARS-CoV-2 assay
The PCR assay yields results in around 30 minutes.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
As simple as performing lateral flow tests with the added benefit of much more accurate results
The Q-POC™ SARS-CoV-2 Assay provides quality rapid PCR results at the Point of Need, with the simplicity and hands on time of a lateral flow test. The test is simple to use and can be run by any trained healthcare professional.
The sealed, self-contained cassette contains all necessary reagents. The time required to prepare the test is under one-minute. The user simply collects a mid-nasal swab sample and tests immediately.
1 min | Collect mid-nasal swab. Place in collection tube. Close cap & mix.
20 sec | Transfer sample into cassette. Residual sample remains for reflex testing.
~ 30 mins | Insert into Q-POC™ and test will run automatically.
30 secs | Review, print results.
Results you can trust and rely on
The Q-POC™ SARS-CoV-2 Assay has been developed to be robust against emerging variants. The test is designed with the most up-to-data sequence information to ensure 100% inclusivity of all known SARS-CoV-2 sequences. The test uses three targets (ORF1, N and S genes) to deliver a single, accurate result.
Meet the pioneers leading change in Point-of-Need PCR testing
Inventor at QuantuMDx reveals how his device is transforming the way we diagnose disease with advanced multiplexing technology, and uncovers how it will ease pressures on the NHS to deliver quality healthcare to all
QuantuMDx launches new PCR respiratory panel
New multiplex panel can detect SARS-CoV-2, Flu A, Flu B & RSV at the Point of Need
